4G/5G promoter PAI-1 gene polymorphism is associated with plasmatic PAI-1 activity in Italians: A model of gene-environment interaction

被引：87

作者：

Burzotta, F

Di Castelnuovo, A

Amore, C

D'Orazio, A

Di Bitondo, R

Donati, MB

Iacoviello, L ^{[1
]}

机构：

[1] Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, Angela Valenti Lab Thrombosis Pharmacol, Dept Vasc Med & Pharmacol, I-66030 Santa Maria Imbaro, Italy

[2] TNO, IVVO, Gaubius Lab, NL-2300 AK Leiden, Netherlands

来源：

THROMBOSIS AND HAEMOSTASIS | 1998年 / 79卷 / 02期

关键词：

D O I：

10.1055/s-0037-1614991

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The PAI-1 gene promoter 4G/5G polymorphism was found to be associated with plasma PAI-1 activity in Northern and Central Europe populations, but no data are available on the association between this polymorphism and PAI-1 levels in Southern Europe countries (such as Italy) where the incidence of ischemic disorders is lower. This study shows that among populations with different incidence of atherothrombotic disorders the 4G/5G PAI-1 gene promoter polymorphism has the same importance in the regulation of plasma PAI-1 activity. Moreover, we have analysed some gene environmental interactions: the correlation between PAI-1 and cholesterol in non dyslipidemic subjects and the correlation between PAI-1 activity and tryglicerides in dyslipidemic subjects differed according to the 4G/5G genotype class. Thus, our findings suggest that, among subjects with or without metabolic disorders such as dyslipidemia, completely different gene-environment interactions may occur.

引用

页码：354 / 358

页数：5

共 27 条

[1] CORRELATIONS BETWEEN T-PA AND PAI-1 ANTIGEN AND ACTIVITY AND T-PA/PAI-1 COMPLEXES IN PLASMA OF CONTROL SUBJECTS AND OF PATIENTS WITH INCREASED T-PA OR PAI-1 LEVELS [J].

ALESSI, MC ;

JUHANVAGUE, I ;

DECLERCK, PJ ;

ANFOSSO, F ;

GUEUNOUN, E ;

COLLEN, D .

THROMBOSIS RESEARCH, 1990, 60 (06) :509-516

[2]

[Anonymous], 1989, SAS STAT US GUID VER

[3]

CAMUSSI A, 1989, METODI STAT SPERIMEN

[4] INCREASED FIBRIN TURNOVER AND HIGH PAI-1 ACTIVITY AS PREDICTORS OF ISCHEMIC EVENTS IN ATHEROSCLEROTIC PATIENTS - A CASE-CONTROL STUDY [J].

CORTELLARO, M ;

COFRANCESCO, E ;

BOSCHETTI, C ;

MUSSONI, L ;

DONATI, MB ;

CARDILLO, M ;

CATALANO, M ;

GABRIELLI, L ;

LOMBARDI, B ;

SPECCHIA, G ;

TAVAZZI, L ;

TREMOLI, E ;

POZZOLI, E ;

TURRI, M ;

CORTELLARO, M ;

COFRANCESCO, E ;

BOSCHETTI, C ;

CARDILLO, M ;

TORRI, M ;

RAINISIO, M ;

GENTILE, G ;

MOREO, G ;

BIANCHI, O ;

LEONARDI, P ;

COLOMBI, M ;

CATALANO, M ;

GALIMBERTI, P ;

RUSSO, U ;

CRESSOTTI, A ;

CARZANIGA, G ;

NOBILI, S ;

NINNO, D ;

DONATI, MB ;

IACOVIELLO, L ;

DEGAETANO, G ;

GABRIELLI, L ;

MARTELLI, E ;

CORSI, G ;

LORENZI, G ;

LOMBARDI, B ;

CARRIERO, MR ;

COLOMBO, R ;

SPECCHIA, G ;

CIOFFI, P ;

SCIRE, A ;

TAVAZZI, L ;

GIANNUZZI, P ;

CORRA, U ;

TEMPORELLI, L ;

MORA, F .

ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (10) :1412-1417

[5] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) LOCUS [J].

DAWSON, S ;

HAMSTEN, A ;

WIMAN, B ;

HENNEY, A ;

HUMPHRIES, S .

FIBRINOLYSIS, 1990, 4 :51-53

[6] GENETIC-VARIATION AT THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 LOCUS IS ASSOCIATED WITH ALTERED LEVELS OF PLASMA PLASMINOGEN-ACTIVATOR INHIBITOR-1 ACTIVITY [J].

DAWSON, S ;

HAMSTEN, A ;

WIMAN, B ;

HENNEY, A ;

HUMPHRIES, S .

ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :183-190

[7]

DAWSON SJ, 1993, J BIOL CHEM, V268, P10739

[8] ALLELE-SPECIFIC INCREASE IN BASAL TRANSCRIPTION OF THE PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE IS ASSOCIATED WITH MYOCARDIAL-INFARCTION [J].

ERIKSSON, P ;

KALLIN, B ;

VANTHOOFT, FM ;

BAVENHOLM, P ;

HAMSTEN, A .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (06) :1851-1855

[9]

Falk G., 1994, Fibrinolysis, V8, P45

[10]

GINSBURG D, 1991, THROMB HAEMOSTASIS, V65, P740

← 1 2 3 →